A practical provider guide for helping patients find Alrex or generic Loteprednol 0.2% in stock. Includes workflow tips, alternative options, and pharmacy tools.
Prescribing Alrex (Loteprednol Etabonate 0.2%) for seasonal allergic conjunctivitis should be the easy part. But increasingly, providers are hearing from patients that they can't fill their prescription because their pharmacy doesn't have it in stock. This guide provides a practical, step-by-step approach to helping your patients access Alrex or an appropriate alternative.
Understanding the current market dynamics is essential for setting patient expectations:
The bottom line: your patients can almost certainly get Loteprednol Etabonate 0.2% filled, but they may need guidance on how to navigate the process — especially if the prescription is written for brand-name Alrex.
When patients report they can't find Alrex, the reasons typically fall into a few categories:
Most chain pharmacies have transitioned from stocking brand-name Alrex to the generic. If the prescription includes a "dispense as written" (DAW) designation, the pharmacy cannot substitute the generic, and the patient leaves empty-handed.
Ophthalmic corticosteroids are not high-volume items at most retail pharmacies. A given CVS or Walgreens location may not carry any Loteprednol products if they don't dispense them regularly. This is especially true for stores not located near ophthalmology or optometry practices.
Even when the medication is physically available, patients may encounter insurance-related barriers:
The single most impactful change is to prescribe Loteprednol Etabonate Ophthalmic Suspension 0.2% rather than brand-name Alrex. This allows the pharmacy maximum flexibility to fill from available stock. Unless you have a specific clinical concern about a particular generic manufacturer's formulation, generic prescribing will solve most access problems.
Practical tip: If your EMR defaults to brand-name Alrex, update your favorites/quick-order sets to default to generic Loteprednol Etabonate 0.2%.
Many payers require documentation that the patient has tried and failed OTC antihistamine eye drops before covering a corticosteroid. Proactively documenting this in your notes — even at the visit where you first recommend OTC drops — will streamline prior authorization if and when you need to escalate to Alrex.
Documentation template: "Patient has used OTC olopatadine (Pataday) for [duration] with inadequate symptom control. Continuing to experience significant [itching/redness/swelling]. Escalating to Loteprednol Etabonate 0.2% for short-term anti-inflammatory management."
When a patient reports difficulty filling their prescription, recommend Medfinder. This tool allows patients to search for Alrex or generic Loteprednol Etabonate 0.2% and see which pharmacies near them have it in stock.
Practical tip: Include Medfinder in your post-visit patient instructions or handouts for allergy prescriptions. A simple note like "If your pharmacy doesn't have this medication, check medfinder.com to find it in stock nearby" can prevent phone calls back to your office.
Build relationships with local independent pharmacies, especially those near your practice. Independent pharmacies often:
Consider maintaining a short list of recommended pharmacies for specialty ophthalmic prescriptions that you can share with patients.
If your practice receives samples from Bausch + Lomb, keep a supply of Alrex samples on hand. These can serve as a bridge for patients who need immediate treatment while they locate a pharmacy with stock. Even a few days of sample medication can make the difference between a patient suffering through allergy symptoms and getting timely relief.
When Alrex or generic Loteprednol 0.2% is genuinely unavailable, or when clinical circumstances warrant a different approach, consider these alternatives:
For a detailed comparison of alternatives, see our guide to Alrex alternatives.
Integrating these strategies into your daily workflow can reduce patient callbacks and improve satisfaction:
Helping patients access Alrex in 2026 requires a proactive approach. By prescribing generically, documenting step therapy compliance, and directing patients to real-time availability tools like Medfinder, you can significantly reduce the friction your patients experience when filling their prescriptions.
The medication access challenge isn't unique to Alrex — it's a growing issue across many ophthalmic specialty products. Building workflows that anticipate these challenges will benefit your practice and your patients well beyond allergy season.
Related provider resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
